vs
J.Jill, Inc.(JILL)与PUMA BIOTECHNOLOGY, INC.(PBYI)财务数据对比。点击上方公司名可切换其他公司
J.Jill, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的2.0倍($150.5M vs $75.5M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs -0.5%),J.Jill, Inc.自由现金流更多($16.0M vs $14.4M),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs 0.1%)
J.Jill是1955年创立于美国马萨诸塞州的女装零售品牌,总部位于马萨诸塞州昆西市,自2017年起公开上市,主打面向女性消费者的服饰产品,在美国本土拥有稳定的线下销售网络与客群基础。
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
JILL vs PBYI — 直观对比
营收规模更大
JILL
是对方的2.0倍
$75.5M
营收增速更快
PBYI
高出28.2%
-0.5%
自由现金流更多
JILL
多$1.6M
$14.4M
两年增速更快
PBYI
近两年复合增速
0.1%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $150.5M | $75.5M |
| 净利润 | $9.2M | — |
| 毛利率 | 70.9% | 69.3% |
| 营业利润率 | 9.9% | 22.7% |
| 净利率 | 6.1% | — |
| 营收同比 | -0.5% | 27.7% |
| 净利润同比 | -25.5% | — |
| 每股收益(稀释后) | $0.60 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
JILL
PBYI
| Q4 25 | $150.5M | $75.5M | ||
| Q3 25 | $154.0M | $54.5M | ||
| Q2 25 | $153.6M | $52.4M | ||
| Q1 25 | $142.8M | $46.0M | ||
| Q4 24 | $151.3M | $59.1M | ||
| Q3 24 | $155.2M | $80.5M | ||
| Q2 24 | $161.5M | $47.1M | ||
| Q1 24 | $150.3M | $43.8M |
净利润
JILL
PBYI
| Q4 25 | $9.2M | — | ||
| Q3 25 | $10.5M | $8.8M | ||
| Q2 25 | $11.7M | $5.9M | ||
| Q1 25 | $2.2M | $3.0M | ||
| Q4 24 | $12.3M | — | ||
| Q3 24 | $8.2M | $20.3M | ||
| Q2 24 | $16.7M | $-4.5M | ||
| Q1 24 | $4.8M | $-4.8M |
毛利率
JILL
PBYI
| Q4 25 | 70.9% | 69.3% | ||
| Q3 25 | 68.4% | 77.7% | ||
| Q2 25 | 71.8% | 76.5% | ||
| Q1 25 | 66.3% | 77.1% | ||
| Q4 24 | 71.4% | 76.4% | ||
| Q3 24 | 70.5% | 63.9% | ||
| Q2 24 | 72.9% | 77.4% | ||
| Q1 24 | 67.5% | 75.5% |
营业利润率
JILL
PBYI
| Q4 25 | 9.9% | 22.7% | ||
| Q3 25 | 10.9% | 17.6% | ||
| Q2 25 | 12.4% | 12.7% | ||
| Q1 25 | 3.6% | 8.7% | ||
| Q4 24 | 12.7% | 22.6% | ||
| Q3 24 | 14.8% | 27.4% | ||
| Q2 24 | 17.6% | -4.6% | ||
| Q1 24 | 7.0% | -5.3% |
净利率
JILL
PBYI
| Q4 25 | 6.1% | — | ||
| Q3 25 | 6.8% | 16.2% | ||
| Q2 25 | 7.6% | 11.2% | ||
| Q1 25 | 1.6% | 6.5% | ||
| Q4 24 | 8.2% | — | ||
| Q3 24 | 5.3% | 25.2% | ||
| Q2 24 | 10.3% | -9.6% | ||
| Q1 24 | 3.2% | -11.0% |
每股收益(稀释后)
JILL
PBYI
| Q4 25 | $0.60 | $0.26 | ||
| Q3 25 | $0.69 | $0.17 | ||
| Q2 25 | $0.76 | $0.12 | ||
| Q1 25 | $0.11 | $0.06 | ||
| Q4 24 | $0.80 | $0.40 | ||
| Q3 24 | $0.54 | $0.41 | ||
| Q2 24 | $1.16 | $-0.09 | ||
| Q1 24 | $0.33 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $58.0M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $129.0M | $130.3M |
| 总资产 | $458.0M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势,按日历期对齐
现金及短期投资
JILL
PBYI
| Q4 25 | $58.0M | $97.5M | ||
| Q3 25 | $45.5M | $94.4M | ||
| Q2 25 | $31.2M | $96.0M | ||
| Q1 25 | $35.4M | $93.2M | ||
| Q4 24 | $38.8M | $101.0M | ||
| Q3 24 | $28.5M | $96.7M | ||
| Q2 24 | $77.1M | $96.8M | ||
| Q1 24 | $62.2M | $107.2M |
总债务
JILL
PBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益
JILL
PBYI
| Q4 25 | $129.0M | $130.3M | ||
| Q3 25 | $121.5M | $115.3M | ||
| Q2 25 | $112.0M | $104.7M | ||
| Q1 25 | $105.8M | $97.1M | ||
| Q4 24 | $103.3M | $92.1M | ||
| Q3 24 | $90.4M | $71.1M | ||
| Q2 24 | $53.1M | $48.5M | ||
| Q1 24 | $37.2M | $51.0M |
总资产
JILL
PBYI
| Q4 25 | $458.0M | $216.3M | ||
| Q3 25 | $436.5M | $202.9M | ||
| Q2 25 | $432.9M | $194.9M | ||
| Q1 25 | $417.7M | $196.2M | ||
| Q4 24 | $418.3M | $213.3M | ||
| Q3 24 | $390.8M | $220.7M | ||
| Q2 24 | $443.9M | $205.0M | ||
| Q1 24 | $428.2M | $214.1M |
负债/权益比
JILL
PBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $19.1M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $16.0M | $14.4M |
| 自由现金流率自由现金流/营收 | 10.6% | 19.1% |
| 资本支出强度资本支出/营收 | 2.0% | 0.0% |
| 现金转化率经营现金流/净利润 | 2.07× | — |
| 过去12个月自由现金流最近4个季度 | $37.6M | $41.7M |
8季度趋势,按日历期对齐
经营现金流
JILL
PBYI
| Q4 25 | $19.1M | $14.4M | ||
| Q3 25 | $19.4M | $9.7M | ||
| Q2 25 | $5.3M | $14.1M | ||
| Q1 25 | $8.1M | $3.6M | ||
| Q4 24 | $19.1M | $15.6M | ||
| Q3 24 | $16.4M | $11.0M | ||
| Q2 24 | $21.5M | $1.0M | ||
| Q1 24 | $6.6M | $11.2M |
自由现金流
JILL
PBYI
| Q4 25 | $16.0M | $14.4M | ||
| Q3 25 | $17.1M | $9.7M | ||
| Q2 25 | $3.1M | $14.1M | ||
| Q1 25 | $1.4M | $3.6M | ||
| Q4 24 | $14.6M | $15.6M | ||
| Q3 24 | $15.0M | $11.0M | ||
| Q2 24 | $19.8M | $1.0M | ||
| Q1 24 | $1.8M | — |
自由现金流率
JILL
PBYI
| Q4 25 | 10.6% | 19.1% | ||
| Q3 25 | 11.1% | 17.7% | ||
| Q2 25 | 2.0% | 26.8% | ||
| Q1 25 | 1.0% | 7.7% | ||
| Q4 24 | 9.7% | 26.4% | ||
| Q3 24 | 9.6% | 13.7% | ||
| Q2 24 | 12.2% | 2.1% | ||
| Q1 24 | 1.2% | — |
资本支出强度
JILL
PBYI
| Q4 25 | 2.0% | 0.0% | ||
| Q3 25 | 1.5% | 0.0% | ||
| Q2 25 | 1.5% | 0.0% | ||
| Q1 25 | 4.7% | 0.1% | ||
| Q4 24 | 2.9% | 0.0% | ||
| Q3 24 | 0.9% | 0.0% | ||
| Q2 24 | 1.1% | 0.0% | ||
| Q1 24 | 3.2% | 0.0% |
现金转化率
JILL
PBYI
| Q4 25 | 2.07× | — | ||
| Q3 25 | 1.84× | 1.10× | ||
| Q2 25 | 0.46× | 2.41× | ||
| Q1 25 | 3.60× | 1.21× | ||
| Q4 24 | 1.54× | — | ||
| Q3 24 | 2.00× | 0.54× | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | 1.39× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
JILL
| Sales Channel Through Intermediary | $80.1M | 53% |
| Sales Channel Directly To Consumer | $70.5M | 47% |
PBYI
暂无分部数据